Beijing SL Pharmaceutical Co Ltd (002038) — Long-term Investment Intensity
Beijing SL Pharmaceutical Co Ltd (002038) has a Long-term Investment Intensity of 11.3% as of September 2019. Long-term investments of CN¥593.47 Million represent 11.3% of total assets of CN¥5.25 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Beijing SL Pharmaceutical Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Beijing SL Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Beijing SL Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 11.3%, reflecting long-term investments of CN¥593.47 Million against total assets of CN¥5.25 Billion CNY. For the complete balance sheet picture, see Beijing SL Pharmaceutical Co Ltd (002038) total assets.
Annual Long-term Investment Intensity for Beijing SL Pharmaceutical Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Beijing SL Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Beijing SL Pharmaceutical Co Ltd (002038) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 10.4% | CN¥520.02 Million | CN¥4.99 Billion | ▲ +5.9 pp |
| 2017 | 4.6% | CN¥209.10 Million | CN¥4.59 Billion | ▼ -2.6 pp |
| 2016 | 7.2% | CN¥292.32 Million | CN¥4.08 Billion | ▲ +0.3 pp |
| 2015 | 6.8% | CN¥257.55 Million | CN¥3.76 Billion | — |